Long-term prospective study of recurrent venous thromboembolism in a Hispanic population

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 7, 2010, Pages 660-665

  Mello, Tayana B T ^a   Orsi, Fernanda L A ^a   Montalvao, Silmara A L ^a   Ozelo, Margareth C ^a   De Paula, Erich V ^a   Annichinno Bizzachi, Joyce M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

recurrence; risk factors; venous thromsbosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; FIBRINOGEN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; FEMALE; GENE MUTATION; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTORS; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; PROTHROMBIN; RECURRENCE; RISK FACTORS; SEX FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77958191358     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833ceaef     Document Type: Article

References (33)

1. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293:2352-2361. (Pubitemid 40676757)
2. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 2007; 92:199-205. (Pubitemid 46852420)
3. Kim TM, Kim JS, Han SW, Hong YS, Kim I, Ha J, et al. Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res 2009; 123:436-443.
4. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
5. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
6. Mello TBT, Montalvão SAL, Ozelo MC, Annichino-Bizzacchi JM. Assessing the interaction of coagulation factor levels, inherited thrombophilia and ABO blood group on the risk for venous thrombosis among Brazilians. Clin Appl Thromb Hemost 2009; 15:408-416.
7. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96:267-273. (Pubitemid 44377808)
8. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and noncarriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thromb Haemost 1999; 81:684-689. (Pubitemid 29216550)
9. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160:761-768. (Pubitemid 30165236)
10. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995; 332:1661-1665.
11. Torresan M, Machado TF, Siqueira LH, Ozelo MC, Arruda VR, Annichino- Bizzacchi JM. The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis. Blood Coagul Fibrinolysis 2000; 11:679-682.
12. Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997; 77:258-261. (Pubitemid 27084911)
13. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7. (Pubitemid 126505333)
14. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82:423-428. (Pubitemid 28023279)
15. Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, et al. Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial. J Thromb Haemost 2006; 4:2199-2203. (Pubitemid 44400298)
16. Grau E, Real E, Medrano J, Pastor E, Selfa S. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting. Thromb Res 1999; 96:335-341.
17. Garcia-Fuster MJ, Forner MJ, Fernandez C, Gil J, Vaya A, Maldonado L. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb 2005; 34:6-12. (Pubitemid 41642799)
18. Ozbudak O, Erogullari I, Ogus C, Cilli A, Turkay M, Ozdemir T. Doppler ultrasonography versus venography in the detection of deep vein thrombosis in patients with pulmonary embolism. J Thromb Thrombolysis 2006; 21:159-162.
19. Righini M, Le Gal G, Aujesky D, Roy PM, Sanchez O, Verschuren F, et al. Complete venous ultrasound in outpatients with suspected pulmonary embolism. J Thromb Haemost 2009; 7:406-412.
20. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 179:417-426.
21. Vossen CY, Walker ID, Svensson P, Souto JC, Scharrer I, Preston FE, et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 2005; 25:1992-1997. (Pubitemid 41243474)
22. van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Buller HR, Girolami A, et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med 1997; 157:2227-2232. (Pubitemid 27451148)
23. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341:801-806. (Pubitemid 29420475)
24. Eichinger S, Minar E, Hirschl M, Bialonczyk C, Stain M, Mannhalter C, et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost 1999; 81:14-17. (Pubitemid 29041641)
25. Lensing AW, Prins MH. Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis? Thromb Haemost 1999; 82:1564-1566.
26. Gonzalez-Porras JR, Garcia-Sanz R, Alberca I, Lopez ML, Balanzategui A, Gutierrez O, et al. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagul Fibrinolysis 2006; 17:23-28. (Pubitemid 43170750)
27. Simioni P, Prandoni P, Lensing AW, Manfrin D, Tormene D, Gavasso S, et al. A. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000; 96:3329-3333.
28. Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, et al. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 2009; 301:2472-2485.
29. Romero A, Alonso C, Rincon M, Medrano J, Santos JM, Calderon E, et al. Risk of venous thromboembolic disease in women: a qualitative systematic review. Eur J Obstet Gynecol Reprod Biol 2005; 121:8-17. (Pubitemid 40884630)
30. Wu O, Robertson L, Langhorne P, Twaddle S, Lowe GD, Clark P, et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005; 94:17-25.
31. Weltermann A, Eichinger S, Bialonczyk C, Minar E, Hirschl M, Quehenberger P, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost 2003; 1:28-32. (Pubitemid 36373372)
32. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343:457-462. (Pubitemid 30646484)
33. Cristina L, Benilde C, Michela C, Mirella F, Giuliana G, Gualtiero P. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 2004; 124:504-510. (Pubitemid 38230597)